LEIDEN, Países Bajos, 11 de abril de 2023 /PRNewswire/ — Pharming Group N.V. (“Pharming”) (Euronext Amsterdam: PHARM) (Nasdaq: PHAR) anuncia los primeros envíos comerciales de Joenja® (leniolisib) a pacientes en Estados Unidos. Joenja®, un inhibidor oral selectivo de PI3Kδ, es el primer…
This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.